Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2026
Mediastinal over-staging with PET-CT in tuberculosis-endemic locally advanced NSCLC: SUV threshold recalibration improves PET/EBUS concordanceManoj Gupta, Irfan Ahmad, Kundan Singh Chufal, et al.Clinical Lung Cancer|August 12, 2024
Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer PatientsPrerana Jha, Asim Joshi, Rohit Mishra, et al.JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced <i>KRAS</i>-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.Oncology Letters|August 22, 2018
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancerSenthil Rajappa, Ashish Joshi, Dinesh C Doval, et al.Oncology and Therapy|October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving SurvivalUllas Batra, Mansi Sharma, Irfan Ahmad, et al.Immunotherapy|September 5, 2025
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gapUllas Batra, Mansi Sharma, Alexis Andrew Miller, et al.Journal of Gastrointestinal Cancer|December 3, 2025
Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North IndiaAbhinav Dewan, Vineet Talwar, Varun Goel, et al.Lung Cancer (Amsterdam, Netherlands)|December 9, 2025
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA studyLin Wu, Junling Li, Chong-Rui Xu, et al.Clinical Lung Cancer|November 27, 2025
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase II trialJames Chih-Hsin Yang, Yuh-Min Chen, Ullas Batra, et al.Pageof 11